“We have colonoscopies, we have mammograms, but we have not had equivalents for most forms of heart disease,”  Pierre Elias, MD, Pathway Labs founder and CEO, explained.

Cardiology remains the No. 2 healthcare specialty for AI approvals, trailing only radiology. 

AI impacts care in so many ways now that it often goes unnoticed by clinicians. 

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

The software-only platform helps clinicians keep track of patients when they are at their most vulnerable.

The newly cleared software alerts clinicians when it detects a suspected vascular occlusion.